Keynote Financial Services LLC Purchases 11,863 Shares of Celularity Inc. (NASDAQ:CELU)

Keynote Financial Services LLC grew its position in shares of Celularity Inc. (NASDAQ:CELU) by 90.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,023 shares of the company’s stock after purchasing an additional 11,863 shares during the period. Keynote Financial Services LLC owned about 0.11% of Celularity worth $52,000 at the end of the most recent reporting period.

Celularity Stock Performance

NASDAQ:CELU opened at $1.16 on Friday. Celularity Inc. has a 1-year low of $1.15 and a 1-year high of $7.97. The business has a 50 day moving average of $2.09 and a 200 day moving average of $2.42.

Celularity (NASDAQ:CELU) last announced its quarterly earnings data on Friday, December 6th. The company reported ($0.73) earnings per share (EPS) for the quarter. Celularity had a negative net margin of 72.72% and a negative return on equity of 119.53%.

About Celularity

Celularity Inc, a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, an allogeneic CAR-T cell for the treatment of non-Hodkin's lymphoma (NHL) and mantle cell lymphoma (MCL); CYNK-001, an allogeneic unmodified natural killer cell that is in Phase I/II clinical trial for the treatment of acute myeloid leukemia (AML); and APPL-001, a genetically modified placental-derived mesenchymal-like adherent stromal cell for the treatment of Crohn's disease.